The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Voices from the coronavirus pandemic, in Italy, New York, and the high seas
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Pharma’s response to coronavirus, Google’s appetite for health data, and biotech’s rise in China
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Wall Street’s coronavirus freakout, why clinical trials frustrate patients, and a journey through the past
By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The Zolgensma lottery, billionaire philanthropy, & life on the buy side
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Fake outbreak news, treating coronavirus, and biotech’s Mount Rushmore
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The latest on the China virus, Sarepta’s ongoing FDA saga, and biotech at Davos
The Readout LOUD By Rebecca Robbins, Damian Garde, and Adam Feuerstein Listen: A J.P. Morgan recap, a plan to bust pharma monopolies, and a website for cancer patients
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The decade in breakthrough drugs, the year in bad CEOing, and the viruses that cure disease
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The future of CAR-T, an alarming cancer trend, and Sarepta’s FDA legacy
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Warren’s awkward home front, the ethics of treating dwarfism, and the sound of STAT Summit
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Google’s data grab, problematic genetic testing, & the perils of biotech Twitter
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: An uncertain Alzheimer’s idea, blockbuster fish oil, & a little self-indulgence
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Drugs that don’t work, wearables in the desert, & excess ‘innovation’
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Every angle on Biogen’s shocking Alzheimer’s news
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Pharma’s future in China, CRISPR meets Netflix, & where VC dollars come from
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Relitigating Vioxx, industry growing pains, & how biotech VC works
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Congressional paralysis, drug shortages, & biotech’s foul mood
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Vaping upheaval, DNA test dynamics, & the future of genome editing
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Unicorn growth spurts, Amgen’s future, & mice on Twitter
The Readout LOUD By Adam Feuerstein and Rebecca Robbins Listen: Pelosi’s drug pricing plan, Moderna’s mRNA drug factories, and a DIY disease cure
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Purdue, J&J, and a week of big opioid crisis news
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The serious side of spit kits, how BiTEs leave a mark, & Sarepta’s sluggish study
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Novartis and the no good, very bad week
